Natalie Dales

Dr. Dales is an accomplished scientist with over 20 years of small molecule drug discovery experience leading and mentoring teams in pharmaceuticals and biotech. Prior to Odyssey, Dr. Dales was an Executive Director and the Head of Portfolio and Strategy for the Global Discovery Chemistry Group at Novartis. She was also a senior advisor for the Novartis Genesis Labs, an internal innovation incubator which fostered and funded disruptive concepts to accelerate drug discovery. Prior to Novartis, she worked at Millennium Pharmaceuticals on oncology, cardiovascular, and metabolism programs. Dr. Dales received her Ph.D. in Organic Chemistry from the University of Wisconsin.